The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia

Published:2014-02 Issue:2 Volume:75 Page:113-118
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Sun Yuan-xin,Kong Hai-li,Liu Chuan-fang,Yu Shuang,Tian Tian,Ma Dao-xin,Ji Chun-yan

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference43 articles.

1. Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia;Szczepanski;Clin Cancer Res,2009

2. Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukemia;Wu;Clin Exp Immunol,2009

3. Characteristics of T-cell immunity in patients with acute leukemia;Parovichnikova;Ter Arkh,2006

4. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways;Buggins;J Immunol,2001

5. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response;Panitsas;Blood,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of T helper cell subsets in the peripheral blood and bone marrow of patients with multiple myeloma;Frontiers in Immunology;2024-09-11

2. The role of IL-22 in cancer;Medical Oncology;2024-09-05

3. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia;Cancer Biology & Therapy;2023-11-14

4. Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system;Biomaterials Research;2023-11-06

5. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy;Clinical and Experimental Medicine;2023-11-04